MDL 28170 (Calpain Inhibitor III), calpain and cathepsin B inhibitor from Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

(1) Overexpression of calpain‑1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNAOncology ReportsApril 16, 2019Changzhao Xu, Xiaoxiao Yu, Yuesheng Zhu, Zhenzhai Cai, Lingmin Yu, Ying Lin, Hejie Yu, Zhanxiong Xue, Lingling Zhoudetected by western blot assay. Third, different concentrations (0, 5, 20 and 40 µg) of MDL28170 (cat. no. ab145601; Abcam), a calpain‑1 inhibitor that binds with active sulfhydryl and influences the Ca2+ binding site,

Citations (1)